CR&T Honors Dr Richard T. Silver with its Humanitarian Award

Key Takeaways

Dr. Richard T. Silver received the CR&T Humanitarian Award, now renamed in his honor, for his significant contributions to medicine.
He is a pioneer in clinical cancer chemotherapy and myeloproliferative neoplasms, known for developing the bone marrow biopsy technique.
Dr. Silver's work includes the clinical application of interferons and extensive research on blood groups and rare blood subgroups.
He has co-chaired 15 international congresses on MPNs and held numerous distinguished visiting professorships globally.

In recognition of his generosity and compassion, the CR&T Board of Directors unanimouslyelected to recognize Dr. Silver with this year’s Humanitarian Award. As uncomfortable as thisaccolade will make Dr. Silver feel, the CR&T Board of Directors also chose to recognize hislegacy by renaming the Humanitarian Award after him and honoring him with the inauguralRichard T. Silver, MD Humanitarian Award.

Dr. Silver is Professor Emeritus of Medicine and Emeritus Director, Richard T Silver MDMyeloproliferative Neoplasms Center, at Weill Cornell Medicine. He received undergraduate and medical degrees from Cornell University and completed an internship and residency(hematology/oncology) at New York Hospital-Cornell Medical Center. He was a ClinicalAssociate at the National Cancer Institute, NIH. As a Visiting Fulbright Professor at theUniversity of Bahia, Salvador, Brazil, Dr. Silver helped establish a residency program, supported by the Rockefeller Foundation. His research included the study of blood groups of indigenous tribes of the Mato Grosso region of the Amazon, which led to his discovery of a rare blood subgroup.

Dr. Silver is an internationally recognized pioneer in clinical cancer chemotherapy and clinical and translational investigations in the myeloproliferative neoplasms (MPNs) and chronic myeloid leukemia. He is particularly known for the broad clinical application of the interferons for treating these diseases and is widely credited with developing and popularizing the use of the bone marrow biopsy technique used worldwide for diagnosing hematologic disorders.

He is a prolific author and lecturer at many national and international meetings and has held many distinguished visiting professorships. He has co-chaired 15 international congresses on MPNs. He has been awarded a number of prestigious awards and honors from institutions worldwide. The Richard T Silver Distinguished Professor of Hematology and Oncology and the Richard T Silver MPN Center at Weill Cornell Medicine have been named in recognition of his contributions to the understanding of cancers and the MPNs.